Michael J. Abernathy, Executive Director, leads Amgen’s Global RA CMC function and is accountable for more than 65 staff globally and a product portfolio of over 85 programs. The extent of Michael’s product oversight and responsibilities traverse molecular discovery, early- and late-stage clinical development, and approved life-cycle programs. He also founded Amgen’s CMC External Engagement function, targeting activities that comprise a CMC focus, promoting company and industry initiatives, engaging with health authorities around the world, and contributing to industry organizations. Michael is also a member of Accumlus Synergy’s executive leadership team, and is the Product Owner for the development of the company’s cloud-based Data Exchange Platform. Michael has been an active contributor to innovation during his 20-plus years as a regulatory affairs professional. He holds degrees from University of the Pacific, California State University, and Colorado State University.